Biogen Idec Inc (NASDAQ:BIIB), Longeveron Inc (NASDAQ:LGVN) - Longeveron, Armed with Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer s Disease, Presenting at AAIC & Headed to Phase 2 Trials
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Alzheimer s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Longeveron Inc (NASDAQ:LGVN) - Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer s Disease Trial Accepted for Developing Topics Presentation at the 2021 Annual Alzheimer s Association International Conference
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.